Femara (Letrozole) Drug Information

The drug Femara® (letrozole) is approved for the treatment of certain types of breast cancer in postmenopausal women. In particular, this drug is licensed for postmenopausal women who have:

Early breast cancer that is hormone receptor-positive and who have had surgery

Taken tamoxifen (Nolvadex®, Soltamox™) for five years after surgery or radiation therapy for breast cancer

Advanced or metastatic (spreading) breast cancer that is either hormone receptor-positive or hormone receptor-unknown.

Side effects are possible with this medicine, and it is not appropriate for everyone, so your healthcare provider needs complete information on your medical history and current medications. This will help him or her make sure that Femara is right for you.

(Click Femara for more information on this drug, including how the active ingredient in it, letrozole, works; possible side effects; dosing guidelines; and more.)

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click
Terms of Use for more information.

You've chosen to add topics from the topic group to your selected topics.

Are you sure you want to add all of these topics?

Are You Sure?

You've chosen to clear all of your selected topics. Remember, you need at least one selected topic to use HealthSavvy. If you choose this option, it cannot be undone, and you'll need to choose at least new topic to continue using your HealthSavvy programs.